Uppsala Monitoring Centre

19/06/2026

📚 New release — Version 10 of the Glossary of ICH Terms and definitions is now available

The glossary combines the definitions from across the current, publicly available guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Download your copy at the link below👇

This glossary combines the terms and definitions included in the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). It was compiled by CIOMS from the publicly available guidelines found on the ICH website.

18/06/2026

Epidemiological outbreaks put systems to the test.

In Tolima, 🇨🇴, a yellow fever outbreak prompted a region-wide effort to enhance vaccine safety surveillance from the grassroots up. The vaccination programme reached the most remote rural areas thanks to expanded coverage, strategic field operations, well-trained healthcare staff, pharmacovigilance tools, and collaboration among key ministries and regional actors.

Ingrid Katherine Rengifo Hernández shares how the collective effort to mitigate the outbreak marked a turning point in Tolima's capacity and enhanced community trust in .

📖 Read their story at the link below👇

A yellow fever outbreak in Tolima, Colombia, put the region's pharmacovigilance system to the test. Here's how rigorous vaccine surveillance protected the community.

17/06/2026

📚 New publication: meeting report

This report takes stock of global perspectives on the evolution and future of presented at the 24th Annual Meeting of ISoP Online, held in Cairo🇪🇬 last year. The report highlights strengthening global PV capacity through collaboration, reliance models, education, and sustainable system development.

𝘛𝘩𝘦 𝘢𝘳𝘵𝘪𝘤𝘭𝘦 𝘪𝘴 𝘥𝘦𝘥𝘪𝘤𝘢𝘵𝘦𝘥 𝘵𝘰 𝘚𝘪𝘵𝘪 𝘈𝘴𝘧𝘪𝘫𝘢𝘩 𝘈𝘣𝘥𝘰𝘦𝘭𝘭𝘢𝘩 𝘪𝘯 𝘳𝘦𝘤𝘰𝘨𝘯𝘪𝘵𝘪𝘰𝘯 𝘰𝘧 𝘩𝘦𝘳 𝘰𝘶𝘵𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘦𝘧𝘧𝘰𝘳𝘵𝘴 𝘢𝘯𝘥 𝘶𝘯𝘸𝘢𝘷𝘦𝘳𝘪𝘯𝘨 𝘤𝘰𝘮𝘮𝘪𝘵𝘮𝘦𝘯𝘵 𝘵𝘰 𝘱𝘳𝘰𝘮𝘰𝘵𝘪𝘯𝘨 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘰𝘷𝘪𝘨𝘪𝘭𝘢𝘯𝘤𝘦 𝘢𝘯𝘥 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘴𝘢𝘧𝘦𝘵𝘺 𝘸𝘰𝘳𝘭𝘥𝘸𝘪𝘥𝘦.

at the link below👇

Home Drug Safety Article Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence FROM THE ISoP Published: 02 June 2026 Volume 49, pages 733–745 (2026) Cite th...

16/06/2026

The run up to 2026 continues 📆

Yesterday, we met with participants to cover all things related to campaign evaluation, including methods for measuring outcomes of online and live events, social media monitoring, and statistical reporting.

Thanks to our colleagues, Ban from Iraq🇮🇶 and Tobias from Sweden🇸🇪, for sharing their evaluation approaches and findings from last year's initiatives.

Join us from 2 to 8 November 2026 as we explore the theme "Side effects – don't ignore them, report them."

🌐 Learn more about the campaign here 👉 who-umc.org/medsafetyweek

وزارة الصحة العراقية Läkemedelsverket

15/06/2026

What happens when medicines enter the environment?

Ecopharmacovigilance and the approach remind us that medicines can enter the environment and may have significant, long-lasting effects on ecosystems, animals, and ultimately, human health. However, understanding these impacts presents unique data and methodological challenges, particularly when compared with traditional .

🎧 Tune in to the latest episode of to hear Joe Mitchell and Valentina Giunchi discuss their insights on here 👉 https://ow.ly/WJJY50Z7TLB

12/06/2026

📚 Can databases be leveraged to identify and monitor antimicrobial resistance trends and inappropriate use?

A new article explores reports submitted to VigiBase in lower-middle income countries (LMICs) to determine if safety surveillance systems can provide important early warnings about possible antimicrobial resistance, especially in places where laboratory testing is limited.

Read the study here 👉 https://onlinelibrary.wiley.com/doi/10.1002/pds.70404

11/06/2026

🍎 Children's first experiences with medicines shape lifelong health beliefs. How can you explain medicines to a child in a reassuring and informed way?

A new educational initiative in Australia is reframing medicine use as a journey of discovery to teach foundational moments in and early safety behaviours through children's literature.

📖 Read to discover how Pharmacy Adventure is helping to strengthen 👉 https://ow.ly/YPea50Z9QMl

10/06/2026

🎥 Signals of adverse drug reactions can be based on different study designs, including clinical trials, observational studies, meta-analyses, and case reports. Daniele Sartori sat down in the Research Corner to shine a light on the evidence base and features of ADR reports.

📖 Access the report for further reading: doi.org/10.1007/s40264-022-01258-0

🎧 Listen to the episode with Daniele: ow.ly/qloX50N0mSR

10/06/2026

Open-source software can enable transparency, reproducibility, and collaboration, yet these initiatives often remain fragmented in .

A new research poster, presented at , explores the feasibility and community interest in open-sourcing pharmacovigilance methods, and what can be done next to support a shared ecosystem of tools.

🐝 Access the latest UMC poster online for more 👉 https://ow.ly/KVJQ50Z9ffs

08/06/2026

From addressing medicine shortages to facilitating data exchange and identifying appropriate substitutes, the pharmaceutical product identifier and the larger set of Identification of Medicinal Products ISO standards, aim to express information on medicines consistently across regions and the globe.

Read how UMC is at heart of a global concerted effort to put the PhPID in IDMP, and how regulators, industry, and stand to benefit in 👇

UMC is at the heart of a concerted effort to develop a panacea for a global headache: How to describe medicines consistently.